Beryl Drugs Ltd vs Desh Rakshak Aushdhalaya Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 18, 2026

Key Highlights

The Latest Trading Price of Beryl Drugs Ltd is ₹ 21.6 as of 18 May 09:09 . The P/E Ratio of Beryl Drugs Ltd changed from 14.1 on March 2021 to 18.5 on March 2025 . This represents a CAGR of 5.58% over 5 yearsThe P/E Ratio of Desh Rakshak Aushdhalaya Ltd changed from 4.5 on March 2021 to 29.5 on March 2025 . This represents a CAGR of 45.65% over 5 years The Market Cap of Beryl Drugs Ltd changed from ₹ 3.35 crore on March 2021 to ₹ 10.68 crore on March 2025 . This represents a CAGR of 26.10% over 5 yearsThe Market Cap of Desh Rakshak Aushdhalaya Ltd changed from ₹ 1.82 crore on March 2021 to ₹ 13.38 crore on March 2025 . This represents a CAGR of 49.03% over 5 years The revenue of Beryl Drugs Ltd for the Dec '25 is ₹ 3.85 crore as compare to the Sep '25 revenue of ₹ 5.16 crore. This represent the decline of -25.39% The revenue of Desh Rakshak Aushdhalaya Ltd for the Dec '25 is ₹ 1.4 crore as compare to the Sep '25 revenue of ₹ 0.95 crore. This represent the growth of 47.37% The ebitda of Beryl Drugs Ltd for the Dec '25 is ₹ -0.2 crore as compare to the Sep '25 ebitda of ₹ 0.73 crore. This represent the decline of -127% The ebitda of Desh Rakshak Aushdhalaya Ltd for the Dec '25 is ₹ 0.25 crore as compare to the Sep '25 ebitda of ₹ 0.26 crore. This represent the decline of -3.85% The net profit of Beryl Drugs Ltd changed from ₹ 0.37 crore to ₹ -0.17 crore over 7 quarters. This represents a CAGR of NaN% The net profit of Desh Rakshak Aushdhalaya Ltd changed from ₹ 0.09 crore to ₹ 0.09 crore over 7 quarters. This represents a CAGR of 0.00% The Dividend Payout of Beryl Drugs Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Desh Rakshak Aushdhalaya Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Beryl Drugs Ltd

Beryl Drugs Limited was incorporated on August 24, 1993.
The Company acquired the running business of M/s Flora and Fauna Remedies Limited on December 15, 1993.
The Shares of Company were listed on M.P. Stock Exchange, Bombay Stock Exchange and Ahmedabad Stock Exchange. The Company thereafter has been engaged in the manufacture, sale, and export of branded, generic pharmaceutical formulations in India and internationally.
It offers I.V. fluids, and a range of small and large volume injectables.
It provides a range of eye/ear drops, veterinary products, and injections.

About Desh Rakshak Aushdhalaya Ltd

The flagship company Desh Rakshak Aushdhalaya Limited of Bhagwant Group was originally started in 1901 as a Proprietorship Concern by Late Shri Bhagwant Rai Jain, a well renowned Vaidya Father of Late Dr. Paras Kumar Jain.
The Concern was converted into a Private Limited Company in Jul.'94. Desh Rakshakare the oldest manufacturer of Pure Ayurvedic and Herbal Products as discovered by the Ancient Seers & Sages.
The medicines are categorized into Proprietary & Classical Medicines.
They are currently manufacturing around 450 products (Proprietary & Classical mix) and all of these medicines are manufactured as per the prescribed norms and standards of the Indian Government.
The Company was earlier operating the traditional process of manufacturing ayurvedic medicines. Up to 1976, the company producing ethical products of ayurvedic medicines which were supplied to ayurvedic dispensaries.

FAQs for the comparison of Beryl Drugs Ltd and Desh Rakshak Aushdhalaya Ltd

Which company has a larger market capitalization, Beryl Drugs Ltd or Desh Rakshak Aushdhalaya Ltd?

Market cap of Beryl Drugs Ltd is 10 Cr while Market cap of Desh Rakshak Aushdhalaya Ltd is 14 Cr

What are the key factors driving the stock performance of Beryl Drugs Ltd and Desh Rakshak Aushdhalaya Ltd?

The stock performance of Beryl Drugs Ltd and Desh Rakshak Aushdhalaya Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Beryl Drugs Ltd and Desh Rakshak Aushdhalaya Ltd?

As of May 18, 2026, the Beryl Drugs Ltd stock price is INR ₹21.15. On the other hand, Desh Rakshak Aushdhalaya Ltd stock price is INR ₹26.04.

How do dividend payouts of Beryl Drugs Ltd and Desh Rakshak Aushdhalaya Ltd compare?

To compare the dividend payouts of Beryl Drugs Ltd and Desh Rakshak Aushdhalaya Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.